What is the treatment for nephrotic syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Nephrotic Syndrome

The treatment of nephrotic syndrome requires rapid referral to a specialized nephrology unit and includes disease-specific therapy targeting the underlying cause, along with supportive measures to manage symptoms and prevent complications. 1

Diagnosis and Classification

Nephrotic syndrome is characterized by:

  • Heavy proteinuria (>3.5g/24h or urine protein:creatinine ratio >300-350 mg/mmol)
  • Hypoalbuminemia (<3.0g/dL)
  • Edema
  • Hyperlipidemia 1

Classification:

  • Congenital/infantile
  • Primary/idiopathic (most common in adults: focal segmental glomerulosclerosis and membranous nephropathy)
  • Secondary (due to diabetes, lupus, infections, etc.) 1, 2

Treatment Algorithm

1. Initial Management

  • Fluid and sodium restriction

    • Restrict oral fluid intake to avoid marked edema
    • Avoid intravenous fluids and saline 3, 1
  • Diuretics

    • Furosemide (0.5-2 mg/kg per dose, up to six times daily; maximum 10 mg/kg per day)
    • Administer at the end of albumin infusions unless marked hypovolemia is present 3
    • Consider combination therapy with thiazide or potassium-sparing diuretics for severe cases 1
  • Antiproteinuric therapy

    • ACE inhibitors or ARBs to reduce proteinuria 1, 2
    • Monitor for hypotension and acute kidney injury

2. Disease-Specific Treatment

For Primary/Idiopathic Nephrotic Syndrome:

  • Corticosteroids

    • High-dose oral prednisone (1mg/kg/day) for 4-16 weeks 1
    • Monitor for side effects, especially in pediatric patients (growth velocity, blood pressure, weight, intraocular pressure) 4
  • For steroid-resistant cases:

    • Calcineurin inhibitors (cyclosporine, tacrolimus)
    • Mycophenolate mofetil
    • Anti-CD20 monoclonal antibodies (rituximab)
    • Cyclophosphamide 1, 5

For Genetic Forms:

  • Avoid immunosuppressive agents as they are typically ineffective 3
  • Consider genetic testing, especially in congenital/infantile cases 1

For Infection-Associated Nephrotic Syndrome:

  • Treat with specific antimicrobial agents 3
  • Screen for congenital infections 3

3. Management of Complications

  • Thromboprophylaxis

    • Consider prophylactic anticoagulation in high-risk patients
    • Recommended when central venous access is required 3, 1
  • Hyperlipidemia

    • Statins for persistent hyperlipidemia 1
  • Edema management

    • Albumin infusions based on clinical indicators of hypovolemia (oliguria, acute kidney injury, prolonged capillary refill time, tachycardia, hypotension)
    • Do not administer albumin based solely on serum albumin levels 3
  • Infection prevention

    • Monitor for signs of infection, especially in immunosuppressed patients 1

4. Special Considerations for Children

  • Monitor growth velocity
  • Consider growth hormone substitution in children with growth issues 3, 1
  • Home administration of albumin infusions may be feasible after proper training 3

5. Monitoring and Follow-up

  • Regular assessment of:

    • Renal function
    • Proteinuria
    • Blood pressure
    • Edema
    • Growth velocity in children 1
  • Response assessment:

    • Complete response: return of serum creatinine to baseline and decline in UPCR to <500-700 mg/g
    • Partial response: stabilization or improvement of serum creatinine but UPCR still >500-700 mg/g 1

When to Consider Kidney Biopsy

  • Adults with nephrotic syndrome without clear etiology
  • Suspected underlying systemic disease (e.g., lupus)
  • Steroid-resistant nephrotic syndrome
  • Atypical presentation or course 1, 2

When to Consider Nephrectomy (for Congenital Nephrotic Syndrome)

  • Persistent hypovolemia
  • Thrombosis
  • Failure to thrive despite optimal management 3

Common Pitfalls and How to Avoid Them

  1. Treating based on serum albumin levels alone

    • Use clinical indicators of hypovolemia instead 3
  2. Overreliance on immunosuppression for genetic forms

    • Perform genetic testing before initiating immunosuppression 3, 1
  3. Fluid overload due to excessive fluid administration

    • Restrict sodium and fluid intake based on volume status assessment 1
  4. Inadequate thromboprophylaxis

    • Consider anticoagulation in high-risk patients 3, 1
  5. Failure to monitor for complications

    • Regular assessment for infections, thrombosis, and growth issues in children 1, 4
  6. Delaying referral to specialists

    • Early referral to nephrology and transplant units when appropriate 3, 1

References

Guideline

Nephritic Syndrome Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diagnosis and Management of Nephrotic Syndrome in Adults.

American family physician, 2016

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Childhood nephrotic syndrome.

Lancet (London, England), 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.